Clinical Trials Directory

Trials / Completed

CompletedNCT04366492

HBV/HCV/HIV in Belgian Prisons

Prevalence of Blood Borne Viral Infections (HBV/HCV/HIV) in the Belgian Prison System

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
3,045 (actual)
Sponsor
Hasselt University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

To assess the prevalence of blood-borne viral infections in prisons in Belgium, screening will be executed in several prisons in Flanders, Brussels and Wallonia to obtain a geographical representative distribution. Upon informed consent screening will be performed using whole capillary blood (finger prick testing) with three different tests for HCV Ab, HBsAg and HIV. Screening will be performed first. While awaiting the test result (15-20min), the participant can fill out a questionnaire (together with the study nurse), concerning risk factors for HCV, HBV and HIV infection. This questionnaire is filled out directly online, and will be immediately implemented in the encoded database. The database is set-up according to the rules of good clinical practice. (Castor EDC software). The results will be filled out immediately by the prison staff in this database after it is filled out by the participant, minimizing the risk of displacement of test results.

Conditions

Interventions

TypeNameDescription
OTHERPrevalence of blood borne viral infections (HBV/HCV/HIV)rapid finger prick test for HCV Ab, HBsAg and HIV and a questionnaire

Timeline

Start date
2019-04-01
Primary completion
2020-03-31
Completion
2020-03-31
First posted
2020-04-29
Last updated
2020-04-29

Locations

2 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04366492. Inclusion in this directory is not an endorsement.